SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is trending as traders discuss its potential for another pump, citing its fully diluted status and history of rapid price movements. Some community members point to the project's underlying technology and cross-chain capabilities while others speculate on potential exchange listings. Overall, there's a debate between those anticipating quick gains and others focused on long-term fundamentals.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as community members discuss its potential to disrupt the financial sector with its high transaction speed, low fees, and institutional-grade compliance features, positioning it as a superior alternative to other blockchains. Discussions highlight Keeta's focus on real-world asset tokenization and integration of identity verification, compliance tools, and its potential for partnerships with major financial institutions. The community also debates Keeta's competitive advantages over established cryptocurrencies and layer-1 solutions.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as community members discuss its potential to outperform Bitcoin, while some point to Grayscale's filing to convert its BCH trust into an ETF as a potential catalyst. Bullish sentiment is fueled by the coin's recent price strength and perceived accumulation, with some anticipating a significant breakout soon. The community is also debating its utility as a faster and cheaper alternative to Bitcoin for transactions.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is trending amid discussions about potential acquisitions, partnerships, and promising pipeline developments. The community is speculating on possible buyout targets and the impact of positive trial results, as well as potential expansion in the global market. News about a potential consumer health unit sale may also be influencing the stock's movement.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is trending as traders discuss its potential following the delisting of its futures on Binance, with some anticipating a pump. The community is focused on the upcoming Goliath mainnet launch and its potential impact on DeFi and TradFi sectors. Others remain skeptical, citing past pump-and-dump schemes and expressing concern over its long-term viability.

Bitcoin on Base is your your second chance at Bitcoin.  Buy BTCB, Hold BTCB, and get airdropped cbBTC. Wrapped Coinbase Bitcoin will be dropped twice a year to wallets holding atleast 2,400 BTCT tokens.   Please update the description to the following:   Bitcoin on Base (BTCB) combines the scarcity of Bitcoin with the speed, security and scalability of Base. Your second chance at Bitcoin has arrived.

Bitcoin on Base

Bitcoin on Base ($BTCB) is surging, sparking excitement as a potential second chance at early Bitcoin-like gains within Coinbase's Base network. Community chatter highlights its increasing popularity and potential for significant growth, with some suggesting it could reach substantial market caps. Discussions also focus on its unique features like Bitcoin mining utility and airdrops to holders.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community discusses its ISO 20022 compliance and the potential launch of its Super App, anticipating a significant impact on the payments sector. Community members are drawing comparisons to other cryptocurrencies and highlighting Zebec's focus on real-world payment infrastructure, suggesting it's undervalued at its current price. The discussion includes its potential role in bridging DeFi with traditional finance.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XDC is trending as the community discusses potential exchange listings and strategic partnerships that could expand the network's role in trade finance. Recent clarifications addressing fund-freezing capabilities have boosted investor confidence. The ongoing DeFi Surge Program is also a key talking point, enhancing liquidity and expanding XDC's utility.

WorldFinancial

World Financial (WLFI) is trending amid discussions about its potential connection to political figures and speculation around upcoming news or updates, including a potential app release. Some community members suggest a possible pump is coming, while others debate its long-term potential and compare it to other cryptocurrencies like Dogecoin. The coin's relationship with Alt 5 Sigma (ALTS) and potential for real-world applications are also being discussed.

Monad

Monad is trending due to its pre-sale launch on Coinbase, with the community actively discussing the high demand and potential allocation sizes. Despite concerns about the timing amid broader market conditions, many are optimistic about the project's potential, drawing comparisons to previous successful launches like Sui. Speculation is building around its future price and the impact of venture capital involvement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These five biotech stocks, all belonging to nano-, small- or mid-cap categories, notched the highest jump in Stocktwits message volume in the week ended Feb. 14, 2025:GlycoMimetics Inc. (+550% jump in chatter)GlycoMimetics, a late-stage biotech firm developing glycobiology-based cancer therapies, saw a surge in retail interest after a minor amendment to its merger agreement with Crescent Biopharma. The update refined the financing structure but kept intact the exchange ratio and ownership split. Once the deal closes, Crescent security holders, including new investors, will own about 96.9% of the combined company. Shares are up roughly 16% year-to-date (YTD).GRAIL Inc. (+500% jump in chatter)Cancer detection firm GRAIL made waves after announcing a partnership with Quest Diagnostics (DGX) to distribute its Galleri multi-cancer early detection test. Analysts at Guggenheim viewed the move as a major step toward broader accessibility. The stock has soared over 208% YTD.ADMA Biologics Inc. (+400% jump in chatter)ADMA Biologics, a biopharma company focused on plasma-derived therapies, saw rising buzz ahead of its upcoming fourth-quarter (Q4) earnings. Last month, it issued a preliminary report projecting full-year 2024 revenue between $417 million and $425 million, with total cash holdings exceeding $100 million. Despite the strong forecast, shares remain down more than 8% YTD.Moleculin Biotech Inc. (+295% jump in chatter)Moleculin Biotech gained traction after the FDA provided guidance on its Phase 3 trial for Annamycin, a next-generation anthracycline designed to treat relapsed/refractory acute myeloid leukemia (AML) and soft tissue sarcoma lung metastases. With an adjusted trial size, the company expects its first unblinding in late 2025 and another in early 2026. Shares have climbed over 25% YTD.Exelixis Inc. (+200% jump in chatter)Exelixis, an oncology-focused biotech, saw a surge in discussions after reporting Q4 earnings that topped estimates, prompting analysts to raise their price targets. Citi highlighted continued strength in its Cabometyx franchise and pointed to Zanza as a potential blockbuster drug. Shares are up 4.35% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

Equity

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.


Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation at...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders...

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders...

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of GlycoMimetics, Inc. (NasdaqGM: GLYC) and...

Integrated Media Technology Limited (<a class="mention" data-mention="$IMTE" data-symbol-id="IMTE" href="https://stocktwits.com/symbol/IMTE" target="_blank">$IMTE</a>)IMTE stock rose 5% pre-market on Wednesday, building on a 9.39% rise to close at $1.98 in the previous session.The uptick in share price comes after the company appointed Zhiyun Tan to its board of directors. Tan has over a decade of experience in business and tax advisory services. According to the tech company, Tan’s addition to the board will bolster its advisory capabilities.<figure class="image"><img style="aspect-ratio:1279/286;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_064506_eab9455f6b.png" alt="Screenshot 2024-10-30 064506.png" width="1279" height="286"><figcaption>IMTE's Sentiment and Message Volume on Oct 30 as of 6:45 a.m. ET | Source: Stocktwits</figcaption></figure>Stocktwits retail sentiment skyrocketed to ‘extremely bullish’ (97/100), its highest mark this year, as message volume hit a one-year peak at ‘extremely high’ (95/100).The stock has lost 23% of its value so far in 2024.GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)GlycoMimetics shares fell 16% pre-market Wednesday, following a massive 191% surge in the prior trading session, after announcing its acquisition of Crescent BioPharma, an oncology therapeutics developer focused on solid tumors.The merger has received approval from the boards of both companies, though closing remains contingent on stockholder approval and other customary conditions, with finalization expected by Q2 2025.Upon completion, GlycoMimetics plans to adopt Crescent Biopharma as its new name, marking a significant pivot in its strategic focus.<figure class="image"><img style="aspect-ratio:1280/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_065931_7a6c00f4c3.png" alt="Screenshot 2024-10-30 065931.png" width="1280" height="282"><figcaption>GlycoMimetics' Sentiment and Message Volume on Oct 30 as of 6:59 a.m. ET | Source: Stocktwits</figcaption></figure> Retail sentiment on Stocktwits has peaked for a second time this year to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.GlycoMimetics’ stock has dipped 85% so far this year.Alphabet Inc. (<a class="mention" data-mention="$GOOG" data-symbol-id="GOOG" href="https://stocktwits.com/symbol/GOOG" target="_blank">$GOOG</a>)Shares of Google-parent Alphabet rose nearly 7% pre-market Wednesday, following a 1.2% gain in the prior session, after reporting strong quarterly earnings post-market close.Alphabet posted revenue of $88.27 billion, surpassing analysts’ expectations of $86.39 billion, and earnings of $2.12 per share, topping Wall Street’s forecast of $1.84 per share.The earnings report highlighted a historic milestone for Google-owned YouTube, which generated $50 billion in revenue for the first time.<figure class="image"><img style="aspect-ratio:1277/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_071149_0e8d6e2f5c.png" alt="Screenshot 2024-10-30 071149.png" width="1277" height="282"><figcaption>Alphabet's Sentiment and Message Volume on Oct 30 as of 7:11 a.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock remains in the ‘extremely bullish’ (92/100) territory with an uptick in chatter to ‘extremely high’ (87/100) amid the earnings buzz.Google’s stock has gained 31% so far in 2024.For updates and corrections email newsroom@stocktwits.com.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/glw-stock-makes-retail-more-bullish-after-q3-earnings/cJ2DsSpRJw">Corning Stock Boosts Retail Bullishness As Wall Street Analysts Raise Price Targets Post Q3 Earnings</a> &nbsp;

Google is among the top 3 most bullish stocks on Stocktwits today

Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today

Retail sentiment is bullish on all three stocks, driven by Google's impressive financial performance, GlycoMimetics' announcement of a merger and potential rebranding, and IMTE's recent board strengthening.

Integrated Media, GlycoMimetic, Alphabet: 3 Stocks Making Retail Most Bullish Pre-Market Today

GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GLYC_sentiment_and_message_volume_Oct_29_2d5d960690.png" alt="GLYC sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of GlycoMimetics surged over 200% on Tuesday, making it the top gainer across U.S. markets and reaching a near two-year high. The biotech firm’s rally follows news of its <a href="https://stocktwits.com/news-articles/markets/equity/glyc-stock-surges-on-acquisition-deal/cJ2uwL4RJq">acquisition agreement</a> with Crescent Biopharma, backed by a $200 million investment commitment from investors including Fairmount, Venrock Healthcare Capital, and BVF Partners.&nbsp;The combined company will operate under the Crescent Biopharma name. Retail sentiment on Stocktwits skyrocketed, shifting to “extremely bullish” (97/100) from “neutral” on Monday.Canaan Inc. ($CAN)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CAN_sentiment_and_message_volume_Oct_29_41df60828f.png" alt="CAN sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of Canaan Inc., a company focused on Bitcoin mining technology, surged nearly 20% to a three-month high on Tuesday as Bitcoin’s price reached a peak of $72,338 — its highest level since April.&nbsp;This Bitcoin surge fueled significant retail interest, causing Canaan’s Stocktwits sentiment score to jump to “extremely bullish” (97/100) from a previous “bearish” outlook.PayPal Holdings Inc. ($PYPL)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/PYPL_sentiment_and_message_volume_Oct_29_7f56a8c668.png" alt="PYPL sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Despite a 3% dip following its <a href="https://stocktwits.com/news-articles/markets/equity/paypal-stock-plummets-mixed-earnings-retail-investors-bullish/cJ2un8iRJm?source_caller=ui&amp;shortlink=sefos10f&amp;pid=ds&amp;af_click_lookback=7d&amp;af_xp=custom">Q3 earnings</a> report on Tuesday, which missed revenue expectations, PayPal saw a wave of retail optimism. The earnings report did exceed profit expectations, and management’s optimistic outlook reassured many investors, lifting Stocktwits sentiment to ‘extremely bullish’ (96/100).&nbsp;The divergence between sentiment and price suggests retail investors are focusing on PayPal’s long-term potential over short-term volatility.For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/tmtg-core-civic-humana-stocks-poised-for-gains-with-trump-victory-retail-sentiment-mixed/cJ2urOCRJp">TMTG, CoreCivic, Humana Stocks Poised For Gains With Trump Victory: Retail Sentiment Mixed</a>

The most bullish stock during Tuesday's mid-day trading | Source: Pixabay

GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today

Acquisition news, Bitcoin ripping higher and management’s confident commentary despite a post-earnings dip are fueling a lot of optimism 

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

GLYC
GlycoMimetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLYC News

GLYCGlycoMimetics Inc